Follicular adenomas exhibit a unique metabolic profile.1H NMR studies of thyroid lesions

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Deja, Stanisław ^a   Dawiskiba, Tomasz ^b   Balcerzak, Waldemar ^b   Orczyk Pawiłowicz, Magdalena ^b   Głód, Mateusz ^b   Pawełka, Dorota ^b   Młynarz, Piotr ^c  

^a UNIVERSITY OF OPOLE   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMA; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOMICS; MULTIVARIATE ANALYSIS; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84893498376     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084637     Document Type: Article

References (47)

1. Eszlinger M, Paschke R (2010) Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns. Mol Cell Endocrinol 322: 29-37. doi:10.1016/j.mce.2010.01.010. PubMed: 20083161.
2. Sakorafas GH (2010) Thyroid nodules; interpretation and importance of fine-needle aspiration (FNA) for the clinician - practical considerations. Surg Oncol 19: 130-139. doi:10.1016/j.suronc.2010.06.003. PubMed: 20620044.
3. Griffith OL, Melck A, Jones SJ, Wiseman SM (2006) Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers. J Clin Oncol 24: 5043-5051. doi:10.1200/JCO.2006.06.7330. PubMed: 17075124. (Pubitemid 46631408)
4. Salabè GB (2001) Pathogenesis of thyroid nodules: histological classification? Biomed Pharmacother 55: 39-53. doi:10.1016/S0753-3322(00)00010- X. PubMed: 11237284.
5. Zhao J, Leonard C, Gemsenjäger E, Heitz PU, Moch H et al. (2008) Differentiation of human follicular thyroid adenomas from carcinomas by gene expression profiling. Oncol Rep 19: 329-337. PubMed: 18202778. (Pubitemid 351176091)
6. UK Cancer Research. Available: http://info.cancerresearchuk.org/ cancerstats/types/thyroid/incidence/uk-thyroid-cancer-incidencestatistics. Accessed February 13, 2013
7. Fischer S, Asa SL (2008) Application of immunohistochemistry to thyroid neoplasms. Arch Pathol Lab Med 132: 359-372. PubMed: 18318579. (Pubitemid 351328811)
8. Sapio MR, Guerra A, Posca D, Limone PP, Deandrea M et al. (2007) Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fine-needle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma. Endocr Relat Cancer 14: 1089-1097. doi:10.1677/ERC-07-0147. PubMed: 18045960. (Pubitemid 351252440)
9. Kouniavsky G, Zeiger MA (2012) The quest for diagnostic molecular markers for thyroid nodules with indeterminate or suspicious cytology. J Surg Oncol 105: 438-443. doi:10.1002/jso.21935. PubMed: 22441894.
10. Nikiforov YE (2011) Molecular diagnostics of thyroid tumors. Arch Pathol Lab Med 135: 569-577. PubMed: 21526955.
11. Serra S, Asa SL (2008) Controversies in thyroid pathology: the diagnosis of follicular neoplasms. Endocr Pathol 19: 156-165. doi:10.1007/s12022-008-9031- 5. PubMed: 18548351.
12. Fiehn O (2002) Metabolomics - the link between genotypes and phenotypes. Plant Mol Biol 48: 155-171. doi:10.1023/A:1013713905833. PubMed: 11860207.
13. Nicholson JK, Lindon JC, Holmes E (1999) 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29: 1181-1189. doi:10.1080/004982599238047. PubMed: 10598751.
14. Silwood CJ, Lynch E, Claxson AW, Grootveld MC (2002) 1H and 13 C NMR spectroscopic analysis of human saliva. J Dent Res 81: 422-427. doi:10.1177/154405910208100613. PubMed: 12097436.
15. Zhang J, Wei S, Liu L, Gowda NGA, Bonney P et al. (2012) NMR-based metabolomics study of canine bladder cancer. Biochim Biophys Acta 1822: 1807-1814. doi:10.1016/j.bbadis.2012.08.001. PubMed: 22967815.
16. Sinclair AJ, Viant MR, Ball AK, Burdon MA, Walker EA et al. (2010) NMR-based metabolomic analysis of cerebrospinal fluid and serum in neurological diseases - a diagnostic tool? NMR Biomed 23: 123-132. PubMed: 19691132.
17. Gao H, Dong B, Jia J, Zhu H, Diao C et al. (2012) Application of ex vivo 1H NMR metabonomics to the characterization and possible detection of renal cell carcinoma metastases. J Cancer Res Clin Oncol 138: 753-761. doi:10.1007/s00432-011-1134-6. PubMed: 22258851.
18. Fan TWM, Lane AN, Higashi RM, Farag MA, Gao H et al. (2009) Altered regulation of metabolic pathways in human lung cancer discerned by 13 C stable isotope-resolved metabolomics (SIRM). Mol Cancer 8. doi:10.1186/1476-4598-8-41.
19. Budczies J, Denkert C, Müller BM, Brockmöller SF, Klauschen F et. al.. (2012) Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue - a GC-TOFMS based metabolomics study. BMC Genomics 13: 334-. doi:10.1186/1471-2164-13-334. PubMed: 22823888.
20. DeFeo EM, Wu CL, McDougal WS, Cheng LL (2011) A decade in prostate cancer: from NMR to metabolomics. Nat. Rev Urol 8: 301-311. doi:10.1038/nrurol. 2011.53.
21. Jiménez B, Mirnezami R, Kinross J, Cloarec O, Keun HC et al. (2013) 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic "field-effects" enables colorectal cancer staging and prognostication. J Proteome Res 12: 959-968. doi:10.1021/pr3010106. PubMed: 23240862.
22. Yao Z, Yin P, Su D, Peng Z, Zhou L et al. (2011) Serum metabolic profiling and features of papillary thyroid carcinoma and nodular goiter. Mol Biosyst 7: 2608-2614. doi:10.1039/c1mb05029j. PubMed: 21713270.
23. Jordan KW, Adkins CB, Cheng LL, Faquin WC (2011) Application of magnetic-resonance-spectroscopy- based metabolomics to the fine-needle aspiration diagnosis of papillary thyroid carcinoma. Acta Cytol 55: 584-589. doi:10.1159/000333271. PubMed: 22156470.
24. Russell P, Lean CL, Delbridge L, May GL, Dowd S et al. (1994) Proton magnetic resonance and human thyroid neoplasia. I: Discrimination between benign and malignant neoplasms. Am J Med 96: 383-388. doi:10.1016/0002-9343(94)90071- X. PubMed: 8166160. (Pubitemid 24127277)
25. Delbridge L, Lean CL, Russell P, May GL, Roman S et al. (1994) Proton magnetic resonance and human thyroid neoplasia. II: Potential avoidance of surgery for benign follicular neoplasms. World J Surg 18: 512-516. doi:10.1007/BF00353751. PubMed: 7725737.
26. Lean CL, Delbridge L, Russell P, May GL, Mackinnon WB et al. (1995) Diagnosis of follicular thyroid lesions by proton magnetic resonance on fine needle biopsy. J Clin Endocrinol Metab 80: 1306-1311. doi:10.1210/jc.80.4.1306. PubMed: 7714105.
27. Fagin JA, Matsuo K, Karmakar A, Chen DL, Tang SH et al. (1993) High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. J Clin Invest 91: 179-184. PubMed: 8423216. (Pubitemid 23037270)
28. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759-767. doi:10.1016/0092-8674(90)90186-I. PubMed: 2188735.
29. Torregrossa L, Shintu L, Chandran JN, Tintaru A, Ugolini C et al. (2012) Toward the Reliable Diagnosis of Indeterminate Thyroid Lesions: A HRMAS NMR-Based Metabolomics Case of Study. J Proteome Res 11: 3317-3325. doi:10.1021/pr300105e. PubMed: 22509853.
30. Miccoli P, Torregrossa L, Shintu L, Magalhaes A, Chandran J et al. (2012) Metabolomics approach to thyroid nodules: a high-resolution magic-angle spinning nuclear magnetic resonance-based study. Surgery 152: 1118-1124. doi:10.1016/j.surg.2012.08.037. PubMed: 23158182.
31. DeLellis RA, Lloyd RV, Heitz PU, Eng C (2004) World Health Organization classification of tumours. Pathology and genetics of tumours of endocrine organs. IARC Press: Lyon.
32. Savorani F, Tomasi G, Engelsen SB (2010) icoshift: A versatile tool for the rapid alignment of 1D NMR spectra. J Magn Reson 202: 190-202. doi:10.1016/j.jmr.2009.11.012. PubMed: 20004603.
33. Dieterle F, Ross A, Schlotterbeck G, Senn H (2006) Probabilistic Quotient Normalization as Robust Method to Account for Dilution of Complex Biological Mixtures. Application in 1 H NMR Metabonomics. Anal Chem 78: 4281-4290. doi:10.1021/ac051632c. PubMed: 16808434.
34. Trygg J, Wold S (2002) Orthogonal projections to latent structures (OPLS). J Chemom 16: 119-128. doi:10.1002/cem.695.
35. Diogo C, Alberto F, Pedro M (2005) The origin of correlations in metabolomics data. Metabolomics 1: 53-63. doi:10.1007/s11306-005-1107-3.
36. Xia J, Wishart DS (2010) MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data. Nucleic Acids Res 38: W71-W77. doi:10.1093/nar/gkq329. PubMed: 20457745.
37. Erickson JW, Cerione RA (2010) Glutaminase: a hot spot for regulation of cancer cell metabolism? Oncotarget 1: 734-740. PubMed: 21234284.
38. Ong ES, Zou L, Li S, Cheah PY, Eu KW et al. (2010) Metabolic profiling in colorectal cancer reveals signature metabolic shifts during tumorigenesis. Mol Cell Proteomics. doi:10.1074/mcp.M900551-MCP200.
39. Moreno A, Rey M, Montane JM, Alonso J, Arús C (1993) 1H NMR spectroscopy of colon tumors and normal mucosal biopsies; elevated taurine levels and reduced polyethyleneglycol absorption in tumors may have diagnostic significance. NMR Biomed 6: 111-118. doi:10.1002/nbm.1940060202. PubMed: 8388705.
40. Rocha CM, Barros AS, Gil AM, Goodfellow BJ, Humpfer E et al. (2010) Metabolic profiling of human lung cancer tissue by 1 H high resolution magic angle spinning (HRMAS) NMR spectroscopy. J Proteome Res 9: 319-332. doi:10.1021/pr9006574. PubMed: 19908917.
41. Bathen TF, Jensen LR, Sitter B, Fjösne HE, Halgunset J et al. (2007) MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status. Breast Cancer Res Treat 104: 181-189. doi:10.1007/s10549-006-9400-z. PubMed: 17061040. (Pubitemid 47086272)
42. Tessem MB, Selnaes KM, Sjursen W, Tranø G, Giskeødegå rd GF et al. (2010) Discrimination of patients with microsatellite instability colon cancer using 1H HR MAS MR spectroscopy and chemometric analysis. J Proteome Res 9: 3664-3670. doi:10.1021/pr100176g. PubMed: 20507057.
43. Moreno A, Arús C (1996) Quantitative and qualitative characterization of 1 H NMR spectra of colon tumors, normal mucosa and their perchloric acid extracts: decreased levels of myo-inositol in tumours can be detected in intact biopsies. NMR Biomed 9: 33-45. doi:10.1002/(SICI)1099- 1492(199602)9:1. PubMed: 8842031.
44. Schmid KW, Farid NR (2006) How to define follicular thyroid carcinoma? Virchows Arch 448: 385-393. doi:10.1007/s00428-006-0162-0. PubMed: 16506015.
45. Arora N, Scognamiglio T, Zhu B, Fahey TJ (2008) Do benign thyroid nodules have malignant potential? An evidence-based review. World J Surg 32: 1237-1246. doi:10.1007/s00268-008-9484-1. PubMed: 18327528.
46. Barden CB, Shister KW, Zhu B, Guiter G, Greenblatt DY et al. (2003) Classification of follicular thyroid tumors by molecular signature: results of gene profiling. Clin Cancer Res 9: 1792-1800. PubMed: 12738736. (Pubitemid 36554606)
47. Trovato M, Grosso M, Vitarelli E, Ruggeri RM, Alesci S et al. (2003) Distinctive expression of STAT3 in papillary thyroid carcinomas and a subset of follicular adenomas. Histol Histopathol 18: 393-399. PubMed: 12647789. (Pubitemid 36362056)